Future therapies for respiratory syncytial virus (RSV) must target both the virus and the immune response to ensure babies ...

We’re still in the early stages of RSV season, but doctors are already worried about a rise in cases. As we head into the peak of 2025 RSV season, parents are once again facing an uptick in cases, ...

Explainer: RSV may not quite have the name recognition that influenza and Covid do, but it's actually causing more winter ...

With holiday parties in full gear, it's that time of year that will eventually lead to people getting sick. Feeling ill after that Christmas or New Year's Eve party? If could be RSV. But how can you ...

The FDA has called out Sanofi’s promotion of respiratory syncytial virus (RSV) antibody Beyfortus in a new untitled letter, ...

Researchers suggest targeting neutrophil-driven inflammatory pathways may be critical for reducing pathology in infant RSV ...

Australians have been warned as Respiratory Syncytial Virus (RSV) cases are expected to surge in the coming weeks.

Respiratory syncytial virus (RSV) is a major cause of respiratory infections, particularly in infants, children under 5 years, and older adults. Its rapid spread makes RSV a serious public health ...

Dual long‑acting antibodies that lock RSV’s fusion protein from two sides protect against RSV A and B and prevent resistance, offering durable protection.

Bengaluru: As seasonal respiratory infections begin to rise, doctors are urging parents to pay closer attention to Respiratory Syncytial Virus, commonly known as RSV. For many chi ...

Viral infections that attack the lungs are among the leading reasons infants are hospitalized. A new treatment may offer ...

Adults aged 18 to 64 years with high-risk conditions demonstrate higher rates of RSV-related LRTD than those without these conditions.